Top Markets
#1 Islamic Coin Islamic Coin +151.51%
#2 Akedo Akedo +69.87%
#3 Glidr Glidr +51.75%
#4 DOVU DOVU +48.42%
#5 Velvet Velvet +46.01%
#6 Cross Cross +36.90%
#7 Black Phoenix Black Phoenix +34.13%
#8 Cap Cap +19.51%
#9 DoubleZero DoubleZero +15.07%
#10 Humanity Humanity +11.75%
Coin of the day
Islamic Coin Islamic Coin
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Hepion Pharmaceuticals, Inc. Hepion Pharmaceuticals, Inc.

Hepion Pharmaceuticals, Inc.

HEPA
Classifica tra le azioni #39071
Hepion Pharmaceuticals, Inc., a U.S.-based biopharmaceutical entity, is... Hepion Pharmaceuticals, Inc., a U.S.-based biopharmaceutical entity, is dedicated to developing therapeutic interventions for chronic hepatic ailments. Central to their efforts is Rencofilstat, a cyclophilin inhibitor that has successfully concluded Phase 2a clinical trials. This compound operates by disrupting multiple pathological pathways implicated in the worsening of liver disease. It is currently progressing through clinical development for non-alcoholic steatohepatitis (NASH) and is additionally being explored in nonclinical research for its potential to reduce liver fibrosis and lessen hepatocellular carcinoma tumor loads in experimental models of NASH. Moreover, Rencofilstat has exhibited antiviral properties against hepatitis B, C, and D viruses through diverse mechanisms. The company, established in 2013 and situated in Edison, New Jersey, rebranded as Hepion Pharmaceuticals, Inc. in July 2019, having previously operated as ContraVir Pharmaceuticals, Inc.
Prezzo delle azioni
$0.0568
Ultima sincronizzazione: 2026-08-13
Capitalizzazione di mercato
$661.36K
Variazione (1 giorno)
11.37%
Variazione (1 anno)
-5.33%
Paese
US
Scambia Hepion Pharmaceuticals, Inc. (HEPA)

Categoria

Healthcare
Il prezzo HEPA con la capitalizzazione del mercato della B
Hepion Pharmaceuticals, Inc. Hepion Pharmaceuticals, Inc.
HEPA
$0.0568
Capitalizzazione di mercato di Hepion Pharmaceuticals, Inc.(HEPA)
Capitalizzazione di mercato: $661.36K
A partire dal August 2026, Hepion Pharmaceuticals, Inc. ha una capitalizzazione di mercato pari a $661.36K. Questo rende Hepion Pharmaceuticals, Inc. la 39071st azienda più preziosa al mondo per capitalizzazione di mercato secondo i nostri dati. La capitalizzazione di mercato è il valore totale delle azioni in circolazione di una società quotata e viene comunemente utilizzata per misurarne il valore.
Storia della capitalizzazione di mercato di Hepion Pharmaceuticals, Inc. dal 2014 al 2026
HEPA in paragone con la classifica dei più popolari stocks
Il prezzo per HEPA Attivo B Capitalizzazione del mercato a B Risultati
Hepion Pharmaceuticals, Inc. Hepion Pharmaceuticals, Inc.
$469,742 $661.36K
NVIDIA Corporation NVIDIA Corporation
NVDA
$5.470T +827,009,900.33%
Hepion Pharmaceuticals, Inc. Hepion Pharmaceuticals, Inc.
$383,647 $661.36K
Apple Inc. Apple Inc.
AAPL
$4.467T +675,434,042.20%
Hepion Pharmaceuticals, Inc. Hepion Pharmaceuticals, Inc.
$358,510 $661.36K
Alphabet Inc. Alphabet Inc.
GOOG
$4.174T +631,179,244.65%
Hepion Pharmaceuticals, Inc. Hepion Pharmaceuticals, Inc.
$317,775 $661.36K
Microsoft Corporation Microsoft Corporation
MSFT
$3.700T +559,462,337.44%
Hepion Pharmaceuticals, Inc. Hepion Pharmaceuticals, Inc.
$245,140 $661.36K
Amazon.com, Inc. Amazon.com, Inc.
AMZN
$2.854T +431,584,807.66%